title: A double-blind placebo-controlled study of rolipram in depressed in-patients.
abstract: In a double-blind study, rolipram, a new phosphodiesterase inhibitor, was com pared to placebo in 20 hospitalized depressed patients. There was a high rate of non- completion (11 out of 20) at 28 days. No difference was found in the clinical improvement between the two groups.
authors.affiliation: Medical College of St Bartholomews Hospital.
authors.forename: M W
authors.initials: MW
authors.lastname: Rowlands
authors.forename: T
authors.initials: T
authors.lastname: Silverstone
authors.forename: J C
authors.initials: JC
authors.lastname: Cookson